FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Comments Sought on Pharmaceutical Quality Terminology

FDA requests comments on a draft document about controlled terminology/vocabulary that applies to a set of coded quality attribute data elements for t...

latest-news-card-1
Medical Devices

Medtronic Recalls MiniMed Pumps Over Batteries

Medtronic recalls (Class 1) its MiniMed Insulin pumps due to concerns about reduced battery life in certain situations.

latest-news-card-1
Medical Devices

FDA Clears PlaqueIQ for Cardiovascular Disease

An Elucid 510(k) gains clearance for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease.

latest-news-card-1
Human Drugs

Thermo Fisher Plant Scrutinized by FDA: Reuters

A Reuters article looks into drug GMP issues raised by FDA inspections over the past decade at Thermo Fisher's Greenville, NC drug contract manufactur...

latest-news-card-1
Medical Devices

CDRH Portal Update Tracks PMA Submissions

FDA updates CDRHs Customer Collaboration Portal to track the progress of PMA applications and accept Small Business Determination requests.

latest-news-card-1
Human Drugs

Drug-Drug Interaction Assessments Lacking: FDA Research

FDA says that 22% of new molecular entities required postmarketing requirements or postmarketing commitments to address knowledge gaps on drugdrug int...

latest-news-card-1
Human Drugs

J&J Discontinues Dengue Virus Antiviral Development

Johnson & Johnson discontinues a Phase 2 study evaluating mosnodenvir for preventing dengue virus in adults aged 18-65 years.

latest-news-card-1
Human Drugs

Tirzepatide Shortage Resolved, FDA Says

FDA says the shortage of Lillys Mounjaro and Zepbound has been resolved but other similar products remain in short supply.

latest-news-card-1
Human Drugs

FDA Lifts Hold on Myotonic Dystrophy Drug

FDA lifts a partial clinical hold on Avidity Biosciences delpacibart etedesiran (del-desiran/AOC 1001) that is being evaluated for treating myotonic d...

latest-news-card-1
Human Drugs

5 Observations on BSO FDA-483

FDA has released the form FDA-483 with five observations from an inspection at the Lakewood, CO-based BSO outsourcing facility.